Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6757258

O=C(NCc1cccs1)c1cc2c(NCc3cnc[nH]3)cccc2s1.O=C(O)C(F)(F)F

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA1A P35348 1/20 0.43
KDM4E B2RXH2 3/20 0.42
ALDH1A1 P00352 2/20 0.42
HSD17B10 Q99714 2/20 0.42
HPGD P15428 6/20 0.40
TSHR P16473 3/20 0.40
USP1 O94782 1/20 0.39
WDR48 Q8TAF3 1/20 0.39
RAB9A P51151 3/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
POLB P06746 2/20 0.38
NPC1 O15118 2/20 0.38
HTT P42858 2/20 0.38
TP53 P04637 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
ADRA1D P25100 2/20 0.37
CPT1A P50416 1/20 0.36
KDM4C Q9H3R0 1/20 0.36
FNTA P49354 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6613124 0.94 ADRA1A (0.48) ADRA1AKDM4EALDH1A1HSD17B10HPGD
Trifluoroacetic Acid SCHEMBL6760834 0.78 FNTA (0.53) FNTAFNTBPGGT1B
SCHEMBL6760839 0.71 FNTA (0.44) ADRA1AFNTAFNTBPGGT1B
SCHEMBL17009252 0.60 RAB9A (0.71) KDM4EALDH1A1HSD17B10HPGDTSHR
Trifluoroacetic Acid SCHEMBL31745110 0.60 POLB (0.46) KDM4EALDH1A1HPGDTSHRUSP1
SCHEMBL6987133 0.60 POLB (0.55) ALDH1A1POLBTP53
SCHEMBL3099001 0.60 ALDH1A1 (0.56) KDM4EALDH1A1HSD17B10HPGDTSHR
SCHEMBL6987138 0.60 KDM1A (0.51)
SCHEMBL6981160 0.59 PTGES (0.49) MEN1KMT2ALMNAGAA
SCHEMBL6077120 0.59 POLB (0.62) KDM4EALDH1A1HSD17B10HPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040204417-A1 Novel benzothienyl or indole derivatives, preparation and use thereof as inhibitors of prenyl transferase proteins PIERRE FABRE MEDICAMENT (FR) 2004-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040204417-A1 Novel benzothienyl or indole derivatives, preparation and use thereof as inhibitors of prenyl transferase proteins CBR1, CBR3, HCCS ADRA1A 2036/4885KDM4E 2166/4885ALDH1A1 2558/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.